UCB · 23 hours ago
Assistant
UCB is a global biopharmaceutical company focusing on neurology and immunology, and they are seeking an Administrative Assistant to provide high-quality administrative and operational support to managers within the Asset Team. The role involves optimizing workflows, coordinating schedules, and maintaining confidentiality to ensure smooth execution of priorities.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Manage complex calendars, correspondence, travel logistics, and expense processes
Coordinate meetings, agendas, materials, logistics, and follow‑up actions
Support department communications, documentation, and presentation development
Monitor budgets, manage purchase orders, and support invoicing processes
Maintain organized digital files using Teams, SharePoint, and OneDrive
Handle confidential matters with discretion and professional judgment
Qualification
Required
5+ years' experience as an executive or administrative assistant
Bachelor's degree or equivalent combination of education and experience
Strong organizational, planning, and multitasking skills
Proficiency in PowerPoint, Excel, Word, and digital collaboration tools
Excellent written and verbal communication skills
Ability to manage sensitive information with discretion
Company
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.
H1B Sponsorship
UCB has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (7)
2023 (3)
2022 (4)
2021 (4)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$201.75MKey Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M
Leadership Team
Recent News
Company data provided by crunchbase